SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
MASLOW MARVIN

(Last) (First) (Middle)
C/O MANHATTAN SCIENTIFICS INC.
405 LEXINGTON AVENUE, 32ND FLOOR

(Street)
NEW YORK NY 10174

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/05/2013
3. Issuer Name and Ticker or Trading Symbol
MANHATTAN SCIENTIFICS INC [ MHTX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 27,897,606 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options 03/07/2007 03/07/2017 Common Stock 10,000,000 0.01 D
Stock Options 01/04/2008 01/04/2018 Common Stock 15,000,000 0.01 D
Warrant 10/11/2007 10/11/2017 Common Stock 800,000 0.13(1) D
Series D Preferred Stock 11/05/2013(2) (3) Common Stock 19,229,273 10 D
Explanation of Responses:
1. These warrant shares were awarded to Mr. Maslow for his services on the Board of Directors.
2. Each share of Series D Preferred Stock is convertible in certain circumstances into such number of shares of common stock of the Company as determined by dividing the stated value of $10.00 by the conversion price of $0.055.
3. N/A
/s/ Marvin Maslow 12/11/2013
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.